| Quarter (USD) | Sep 21 | Jun 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 337.85 mm | 337.85 mm | 337.85 mm | 337.85 mm | 337.85 mm | 337.85 mm |
| Cash burn (monthly) | (no burn) | 32.79 mm | 23.54 mm | 21.29 mm | 23.63 mm | 21.78 mm |
| Cash used (since last report) | n/a | 1.27 bn | 913.45 mm | 826.05 mm | 916.78 mm | 845.02 mm |
| Cash remaining | n/a | -934.19 mm | -575.60 mm | -488.20 mm | -578.93 mm | -507.17 mm |
| Runway (months of cash) | n/a | -28.5 | -24.4 | -22.9 | -24.5 | -23.3 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 674.78 mm |
| Total shares | 7.01 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BMY Bristol-Myers Squibb | 7.01 mm | $674.78 mm |
